Innate and adaptive immune responses in neurodegeneration and repair

Immunology

Volumn 141, Issue 3, 2014, Pages 287-291

  Amor, Sandra ^a,b   Woodroofe, M Nicola ^c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

Inflammation; Innate immunity; Multiple sclerosis; Neuroimmunology; Regulatory T cells

Indexed keywords

ADAPTIVE IMMUNITY; CELL INTERACTION; EFFECTOR CELL; HUMAN; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MAST CELL; MICROGLIA; NERVE DEGENERATION; NEUROMODULATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE;

INFLAMMATION; INNATE IMMUNITY; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; REGULATORY T CELLS;

ADAPTIVE IMMUNITY; ANIMALS; CELL COMMUNICATION; CENTRAL NERVOUS SYSTEM; HUMANS; IMMUNITY, INNATE; MAST CELLS; MICROGLIA; NERVE REGENERATION; NEURODEGENERATIVE DISEASES; OLIGODENDROGLIA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 84893579839     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12134     Document Type: Review

References (23)

1. Medawar PB. The Nobel Lectures in Immunology. The Nobel Prize for Physiology or Medicine, 1960. Immunological tolerance. Scand J Immunol 1991; 33:337-44.
2. Kwidzinski E, Mutlu LK, Kovac AD et al. Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model. J Neural Transm Suppl 2003; 65:29-49.
3. Wimo A, Winblad B, Aguero-Torres H, von Strauss E. The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord 2003; 17:63-7.
4. Amor S, Puentes F, Baker D, van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010; 129:154-69.
5. Evans MC, Couch Y, Sibson N, Turner MR. Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Mol Cell Neurosci 2013; 53:34-41.
6. Guillot-Sestier MV, Town T. Innate immunity in Alzheimer's disease: a complex affair. CNS Neurol Disord Drug Targets 2013. [Epub ahead of print].
7. Granata T, Cross H, Theodore W, Avanzini G. Immune-mediated epilepsies. Epilepsia 2011; 52(Suppl 3):5-11.
8. Huizinga R, van der Star BJ, Kipp M et al. Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis. Glia 2012; 60:422-31.
9. van Noort JM, Baker D, Amor S. Mechanisms in the development of multiple sclerosis lesions: reconciling autoimmune and neurodegenerative factors. CNS Neurol Disord Drug Targets 2012; 11:556-69.
10. Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H. The brain tumor microenvironment. Glia 2012; 60:502-14.
11. Rosenfeld MR, Dalmau JO. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis. Continuum (Minneap Minn) 2012; 18:366-83.
12. Kira J. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders. J Neurol Sci 2011; 311:69-77.
13. Cao JJ, Li KS, Shen YQ. Activated immune cells in Parkinson's disease. J Neuroimmune Pharmacol 2011; 6:323-9.
14. Chamorro Á, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol 2012; 8:401-10.
15. Ward RJ, Crichton RR, Taylor DL, Della Corte L, Srai SK, Dexter DT. Iron and the immune system. J Neural Transm 2011; 118:315-28.
16. Suzuki Y, Inoue T, Ra C. Autoimmunity-inducing metals (Hg, Au and Ag) modulate mast cell signaling, function and survival. Curr Pharm Des 2011; 17:3805-14.
17. Woodcock T, Morganti-Kossmann MC. The role of markers of inflammation in traumatic brain injury. Front Neurol 2013; 4:1-18.
18. Cunningham C. Systemic inflammation and delirium: important co-factors in the progression of dementia. Biochem Soc Trans 2011; 39:945-53.
19. van Noort JM, Bsibsi M, Gerritsen WH, van der Valk P, Bajramovic JJ, Steinman L, Amor S. αb-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions. J Neuropathol Exp Neurol 2010; 69:694-703.
20. van der Valk P, Amor S. Preactive lesions in multiple sclerosis. Curr Opin Neurol 2009; 22:207-13.
21. Vogel DY, Vereyken EJ, Glim JE et al. Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation 2013; 10:35.
22. Uccelli A, Laroni A, Freedman MS. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol 2011; 10:649-56.
23. Giunti D, Parodi B, Usai C, Vergani L, Casazza S, Bruzzone S, Mancardi G, Uccelli A. Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1. Stem Cells 2012; 30:2044-53.